Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mauro Gacci

Showing results (11-20 of 253) with videos related to

Pageof 26
Sort By:
European Urology|June 20, 2012
Re: Matthias Oelke, François Giuliano, Vincenzo Mirone, et al., monotherapy with tadalafil or tamsulosin similarly improved lower urinary tract symptoms suggestive of benign prostatic hyperplasia in an international, randomised, parallel, placebo-controlled clinical trial. Eur Urol 2012;61:917-25Mauro Gacci, Mario Maggi, Marco Carini
Biomarkers in Medicine|November 16, 2023
Unveiling prostatic inflammation to optimize management of lower urinary tract symptoms: a discussion with expertsMauro Gacci, Cosimo De Nunzio, Stavros Gravas
World Journal of Urology|February 16, 2020
Inflammation is a target of medical treatment for lower urinary tract symptoms associated with benign prostatic hyperplasiaCosimo De Nunzio, Andrea Salonia, Mauro Gacci, et al.
World Journal of Urology|June 12, 2020
Correction to: Inflammation is a target of medical treatment for lower urinary tract symptoms associated with benign prostatic hyperplasiaCosimo De Nunzio, Andrea Salonia, Mauro Gacci, et al.
Journal of Clinical Medicine|December 11, 2022
The Role of Combination Therapy with α-Blockers and Hexanic Extract of <i>Serenoa repens</i> in the Treatment of LUTS/BPHCosimo De Nunzio, Andrea Salonia, Mauro Gacci, et al.
European Urology|August 9, 2022
Reply to Meny Lv, Xufei Luo, and Yaolong Chen's Letter to the Editor re: Mauro Gacci, Vasileios I. Sakalis, Markos Karavitakis, et al. European Association of Urology Guidelines on Male Urinary Incontinence. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.05.012Mauro Gacci, Vasileios I Sakalis, Markos Karavitakis, et al.
European Urology|November 7, 2016
Reply to Jae Heon Kim's Letter to the Editor re: Mauro Gacci, Giovanni Corona, Arcangelo Sebastianelli, et al. Male Lower Urinary Tract Symptoms and Cardiovascular Events: A Systematic Review and Meta-analysis. Eur Urol 2016;70:788-96Mauro Gacci, Linda Vignozzi, Giovanni Corona, et al.
Urology|March 7, 2002
Leiomyoma of the corona glans penisRiccardo Bartoletti, Mauro Gacci, Gabriella Nesi, et al.
European Urology|October 15, 2013
Tadalafil once daily in men with erectile dysfunction: an integrated analysis of data obtained from 1913 patients from six randomized, double-blind, placebo-controlled, clinical studiesHartmut Porst, Mauro Gacci, Hartwig Büttner, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|January 25, 2014
Serum levels of sex hormone binding globulin (SHBG) are not predictive of prostate cancer diagnosis and aggressiveness: results from an Italian biopsy cohortCosimo De Nunzio, Riccardo Lombardo, Simone Albisinni, et al.
Pageof 26

Showing results (11-20 of 253) with videos related to

Sort By:
Pageof 26
European Urology|June 20, 2012
Re: Matthias Oelke, François Giuliano, Vincenzo Mirone, et al., monotherapy with tadalafil or tamsulosin similarly improved lower urinary tract symptoms suggestive of benign prostatic hyperplasia in an international, randomised, parallel, placebo-controlled clinical trial. Eur Urol 2012;61:917-25Mauro Gacci, Mario Maggi, Marco Carini
Biomarkers in Medicine|November 16, 2023
Unveiling prostatic inflammation to optimize management of lower urinary tract symptoms: a discussion with expertsMauro Gacci, Cosimo De Nunzio, Stavros Gravas
World Journal of Urology|February 16, 2020
Inflammation is a target of medical treatment for lower urinary tract symptoms associated with benign prostatic hyperplasiaCosimo De Nunzio, Andrea Salonia, Mauro Gacci, et al.
World Journal of Urology|June 12, 2020
Correction to: Inflammation is a target of medical treatment for lower urinary tract symptoms associated with benign prostatic hyperplasiaCosimo De Nunzio, Andrea Salonia, Mauro Gacci, et al.
Journal of Clinical Medicine|December 11, 2022
The Role of Combination Therapy with α-Blockers and Hexanic Extract of <i>Serenoa repens</i> in the Treatment of LUTS/BPHCosimo De Nunzio, Andrea Salonia, Mauro Gacci, et al.
European Urology|August 9, 2022
Reply to Meny Lv, Xufei Luo, and Yaolong Chen's Letter to the Editor re: Mauro Gacci, Vasileios I. Sakalis, Markos Karavitakis, et al. European Association of Urology Guidelines on Male Urinary Incontinence. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.05.012Mauro Gacci, Vasileios I Sakalis, Markos Karavitakis, et al.
European Urology|November 7, 2016
Reply to Jae Heon Kim's Letter to the Editor re: Mauro Gacci, Giovanni Corona, Arcangelo Sebastianelli, et al. Male Lower Urinary Tract Symptoms and Cardiovascular Events: A Systematic Review and Meta-analysis. Eur Urol 2016;70:788-96Mauro Gacci, Linda Vignozzi, Giovanni Corona, et al.
Urology|March 7, 2002
Leiomyoma of the corona glans penisRiccardo Bartoletti, Mauro Gacci, Gabriella Nesi, et al.
European Urology|October 15, 2013
Tadalafil once daily in men with erectile dysfunction: an integrated analysis of data obtained from 1913 patients from six randomized, double-blind, placebo-controlled, clinical studiesHartmut Porst, Mauro Gacci, Hartwig Büttner, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|January 25, 2014
Serum levels of sex hormone binding globulin (SHBG) are not predictive of prostate cancer diagnosis and aggressiveness: results from an Italian biopsy cohortCosimo De Nunzio, Riccardo Lombardo, Simone Albisinni, et al.
Pageof 26